Genetic Epidemiology of Cutaneous Melanoma

2001/11/01 by Alisa M. Goldstein, M. A. Tucker, Margaret A. Tucker · 27 citations
Medicine · Computer Science · #Cutaneous Melanoma Detection and Management #Computational Drug Discovery Methods #Skin Protection and Aging

paper · doi:10.1001/archderm.137.11.1493

Abstract

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue

Cited by

• Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families
• Hereditary melanoma: Update on syndromes and management
• Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations. [europepmc]
• Deletion at chromosome arm 9p in relation to BRAF/NRAS mutations and prognostic significance for primary melanoma. [europepmc]
• Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma. [europepmc]
• Duplication of CXC chemokine genes on chromosome 4q13 in a melanoma-prone family. [europepmc]
• LINE-1 methylation in peripheral blood and the risk of melanoma in melanoma-prone families with and without CDKN2A mutations. [europepmc]
• Melanoma survivors: health behaviors, surveillance, psychosocial factors, and family concerns. [europepmc]
• Dysplastic nevi and melanoma. [europepmc]
• Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. [europepmc]
• Constitutional promoter methylation and risk of familial melanoma. [europepmc]
• Constitutive mitochondrial DNA copy number in peripheral blood of melanoma families with and without CDKN2A mutations. [europepmc]
• Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families. [europepmc]
• Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome. [europepmc]
• Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations. [europepmc]
• Rare Germline Copy Number Variations and Disease Susceptibility in Familial Melanoma. [europepmc]
• Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families. [europepmc]
• Cutaneous melanoma: From pathogenesis to therapy (Review). [europepmc]
• Pediatric melanoma in melanoma-prone families. [europepmc]
• Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT. [europepmc]
• Familial Melanoma and Susceptibility Genes: A Review of the Most Common Clinical and Dermoscopic Phenotypic Aspect, Associated Malignancies and Practical Tips for Management. [europepmc]
• Molecular Markers and Targets in Melanoma. [europepmc]
• Etiologies of Melanoma Development and Prevention Measures: A Review of the Current Evidence. [europepmc]
• Novel loss-of-function variant in DENND5A impedes melanosomal cargo transport and predisposes to familial cutaneous melanoma. [europepmc]
• Melanoma therapeutics: a literature review. [europepmc]
• Cutaneous malignant melanoma incidence is strongly associated with European depigmented skin type regardless of ambient ultraviolet radiation levels: evidence from Worldwide population-based data. [europepmc]
• Risk Factors and Innovations in Risk Assessment for Melanoma, Basal Cell Carcinoma, and Squamous Cell Carcinoma. [europepmc]

Related

• Psoriasis Bench to Bedside
• Resident's Page
• Breast Cancer Overdiagnosis Common Among Older Women
• Distinct Sets of Genetic Alterations in Melanoma
• Seronegative Secondary Syphilis in 2 Patients Coinfected With Human Immunodeficiency Virus